Platome Biotechnology

Founded 2016 Iceland

Iceland 2-10 employees Grant Total: $165.00K Biopharma, Biotechnology +1

Platome Biotechnology, founded in 2016 and headquartered in Iceland, specializes in providing scientists with high-quality solutions for growing cells and tissues in the laboratory without the use of animal-derived serum. The company's products, known as platelet lysates, are free of animal components and are made from clinically approved material, providing a more suitable alternative to currently used techniques with animal serum. These platelet lysates enable scientists to grow cells more effectively, particularly stem cells, saving time, effort, and increasing the overall quality of their research. Platome Biotechnology's recent investment of $165.00K in grant funding, received on 19 December 2016, came from the Technology Development Fund. The company operates within the Biopharma, Biotechnology, and Life Sciences industries, positioning itself at the intersection of innovation in biotechnology and the growing demand for animal-free laboratory solutions. With its focus on ethical and high-quality scientific advancements, Platome Biotechnology presents an intriguing opportunity for consideration by venture capital firms seeking to invest in the rapidly evolving biotech sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$165.00K	1	Technology Development Fund	19 Dec 2016

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$165.00K

Technology Development Fund

19 Dec 2016

FAQ About Platome Biotechnology

At Platome Biotechnology we provide scientists with high-quality solutions to grow cells and tissues in the laboratory without the use of animal-derived serum. The products we have to offer, called platelet lysates, are free of animal components and are made from clinically approved material. They c...

Platome Biotechnology was founded in 2016.

Platome Biotechnology is headquartered in Iceland.

Platome Biotechnology operates in Biopharma, Biotechnology and Life Sciences. Its work centres on Cell Culture, Stem Cells, Platelet Lysates and Animal Component-Free.

Platome Biotechnology has approximately 2-10 employees.

Platome Biotechnology has completed 1 funding round, raising a total of $165.00K. The latest funding stage is Grant.

Top alternatives and competitors to Platome Biotechnology include Qkine, Agulos Biotech LLC, MICA Biosystems, TreeFrog Therapeutics, 士泽生物医药. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Platome Biotechnology and Qkine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Platome Biotechnology

Funding Rounds & Investors (1)

Platome Biotechnology Alternatives & Competitors

FAQ About Platome Biotechnology